NCT00154414已完成2 期
Effect of Liraglutide on Glycaemic Control in Japanese Subjects With Type 2 Diabetes.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 226
- 试验地点
- 2
- 主要终点
- HbA1c
研究概览
简要总结
This trial is conducted in Japan. The aim of this research trial is to evaluate the effect of treatment with liraglutide or placebo on blood glucose control after 14 weeks in Japanese subjects with type 2 diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The trial is a multi-national trial with treatment concealed to participating subjects, investigators and the sponsor. Treatment allocation is random with equal chance of being assigned to each group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects diagnosed with type 2 diabetes and treated with diet therapy with or without single oral drug therapy
- •7.0 % =< HbA1c < 10.0 %
- •Body Mass Index (BMI) < 30.0 kg/m^2
排除标准
- •Subjects treated with thiazolidinediones or insulin
- •Subjects with any serious medical conditions
结局指标
主要结局
HbA1c
时间窗: after 14 weeks treatment
次要结局
- Body weight after 14 weeks.
- Glycaemic control parameters (fasting plasma glucose, post prandial plasma glucose) after 14-week treatment
- Safety and tolerability
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00393718Novo Nordisk A/S400
已完成
3 期
Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00395746Novo Nordisk A/S264
已完成
2 期
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00154401Novo Nordisk A/S177
已完成
1 期
Effect of NN5401 in Japanese Subjects With Type 1 DiabetesDiabetes Mellitus, Type 1DiabetesNCT01051102Novo Nordisk A/S21
已完成
3 期
Liraglutide in Adolescents With Type 1 DiabetesType 1 DiabetesNCT02516657University at Buffalo5